Recently, the "Seminar on New Quality Productivity and High-Quality Development in Biomanufacturing, and Cooperation Signing Ceremony" was convened in Beijing, jointly organised by China Great Wall Asset Management Corporation Limited, XI'AN APP-CHEM BIO (TECH) CO., Ltd (APPCHEM), and Guosheng Think Tank. Centred on the theme "Actively Harnessing New Quality Productivity to Anchor High-Quality Development in Biomanufacturing", representatives from government, industry, academia, research, media, and finance gathered at the headquarters conference room of China Great Wall Asset Management Corporation Limited. They collectively explored industrial innovation pathways and witnessed a pivotal moment in the deep integration of financial capital and technology enterprises.
- Corporate Practice: Green Innovation Cultivating High-Value Tracks
The symposium commenced with a promotional video for APPCHEM, highlighting the company's technological expertise and industrial advantages in natural ingredient biomanufacturing. Hu Yongwei, Chairman of XI'AN APP-CHEM BIO (TECH) CO., Ltd (APPCHEM), stated that as a nationally recognised "High-Tech Enterprise" and "Specialised, Refined, Distinctive and Innovative" enterprise, the company has dedicated itself to the natural ingredient biomanufacturing sector. By focusing on high-value innovative ingredient research and development, efficiently utilising renewable raw materials, and optimising production processes, Tianmei has achieved dual reductions in resource consumption and environmental impact. This establishes an efficient and sustainable production model that precisely aligns with the national innovation-driven development strategy. Leveraging domestic resources and talent advantages, biomanufacturing is emerging as a core enabler for the green transformation of traditional industries. This collaboration with Great Wall Asset Management will accelerate the iterative development of high-value natural products, propel industrial upgrading and sustainable development, and provide a practical model for implementing new productive forces.
- Financial Empowerment: Precision Funding Facilitates Technology Commercialisation
Huang Qiang, Deputy General Manager of China Great Wall Asset Management's Capital Markets Department, outlined the company's core business achievements. In recent years, it has maintained an industry-leading position in listed company M&A and restructuring projects, with notable success in emerging industry investments. This has established a comprehensive service model encompassing "M&A + Investment + Empowerment". As a central financial enterprise, Great Wall Asset focuses on strategic sectors such as high technology and healthcare, aligning closely with the "14th Five-Year Plan for Bioeconomic Development" directive to enhance financial support for biomanufacturing. He emphasised that APPCHEM's development in the health and natural nutrition sectors aligns with the "Healthy China" strategy, with its bio-manufacturing track falling within the scope of new productive forces prioritised by the state. "The company will leverage its strengths in financial resource integration to provide APPCHEM with comprehensive support, including financing for technological R&D and supply chain consolidation. By channelling financial resources with precision, we will nurture technology enterprises and facilitate the industrialisation of innovative achievements."
- Strategic Guidance: Macro-level Industry Perspective and Platform Development
Mr Zhang Yuzhong, former Deputy Director-General of the Investment Promotion Bureau at the Ministry of Commerce, attended the conference and offered guiding recommendations for industry development. He noted that China's pharmaceutical foreign trade currently presents both opportunities and challenges. The Ministry of Commerce is actively advancing high-level opening-up to support enterprises in expanding overseas. From a national strategic perspective, China's biomedicine manufacturing sector continues to expand in scale, with increasingly robust foundational development and favourable growth momentum, establishing itself as a vital component within the nation's strategic development framework. Regarding future industry development, Zhang proposed organising major events in the biomedicine manufacturing field. Utilising conferences as platforms with themes closely aligned to national development strategies, he advocated planning and preparing for a "World Biomedicine Manufacturing Development Conference" centred on the theme of "New Quality Productivity and High-Quality Development in Life Sciences". By integrating thematic conferences with exhibition displays, the initiative would extensively showcase advanced technologies and exemplary products within the biomaterials manufacturing sector to diverse sectors of society, thereby raising broader awareness and attention towards the developmental potential of this cutting-edge industry.
- Expert Analysis: Biomanufacturing Emerges as Core Track for New Quality Productive Forces
Tian Huimin, a special researcher at the Beijing Institute of Reform and Development, interprets the industrial value from a national strategic perspective, highlighting that biomedicine represents a pivotal track within new quality productive forces. Leveraging disruptive technologies such as gene editing, synthetic biology, and AI-driven innovations, it is reshaping material production paradigms. Its strategic value manifests across three dimensions: alleviating resource and environmental pressures, ensuring self-reliance and control over critical raw materials, and enhancing global competitiveness in manufacturing. Tian emphasised that biomedicine is driving low-carbon transformation across materials, food, and pharmaceutical sectors. National Bureau of Statistics data indicates sustained growth exceeding 15% in the biopharmaceutical manufacturing industry. "Accelerating biomedicine development is crucial for cultivating new productive forces and fortifying industrial chain security, with the potential to foster leading enterprises in specialised fields."
- Think Tank Support: Industry-Academia-Research Integration to Build Innovation Ecosystem
Xu Yunfeng, Executive Director of Guosheng Think Tank, stated that the establishment of the "Belt and Road" Traditional Chinese Medicine Innovation and Development Research Base by Guosheng Think Tank and Xi'an Tianmei Bio is an innovation consortium focused on traditional Chinese medicine and biomedicine. As a vital platform for deep industry-academia-research integration, the base has facilitated multiple core technology transfers, implemented the "off-site R&D + local conversion" model, and provided enterprises with intellectual support, including policy consultation, industrial research, and resource allocation. This aids in constructing a full-chain innovation ecosystem spanning "R&D-conversion-industrialisation," aligning with national ministries' initiatives to enhance pilot-scale production capabilities in biomanufacturing.
- Multi-stakeholder Discussions: Collaborative Efforts to Drive Industrial Upgrading
Distinguished speakers, including Huang Hairong, Editor-in-Chief of Xinhua Net's Listed Companies Research Institute; Hu Jun, Editor-in-Chief of China.org.cn's Government Affairs; and Wang Nan, Project Director of the Cultural Media and Public Welfare Division at People's Political Consultative Conference Daily, attended and addressed the forum. Huang Hairong highlighted from a capital perspective that biomanufacturing enterprises, leveraging technological barriers and policy incentives, have become a focal point in capital markets. Hu Jun advocated accelerating the establishment of industrial standards to facilitate efficient market access for products. Wang Nan emphasised expanding application scenarios, suggesting promoting diversified use of biomanufactured products in healthcare, green energy, and other sectors. Participants unanimously agreed this collaboration exemplifies the synergistic empowerment of industry through "technology + finance + think tanks".
- Strategic Signing: Joining Forces to Launch a New Chapter of Development
Following in-depth discussions and intellectual exchanges, XI'AN APP-CHEM BIO (TECH) CO., Ltd (APPCHEM) and China Great Wall Asset Management Corporation, Shaanxi Branch formally signed a strategic cooperation agreement. Under the agreement, both parties will integrate technological R&D and financial resource strengths, focusing on key areas such as natural high-value product development and industrial chain upgrading to jointly explore new pathways for high-quality development in biomedicine. As a national strategic emerging industry and future-oriented sector, the biomedicine manufacturing industry holds particular significance for a nation like ours with constrained strategic resources and per capita resources! Driven by dual engines of technological innovation and policy support, China's biomedicine manufacturing sector is accelerating its development, revolutionising material production and acquisition technologies. It stands as a pivotal engine and core component of our nation's new industrialisation drive. This strategic partnership will further synergise technological innovation with financial backing in critical strategic industries, injecting fresh momentum into the high-quality development of the market economy while bolstering the implementation of the "Healthy China" and "Manufacturing Powerhouse" initiatives.
Source
- XINHUANET: http://www.xinhuanet.com/finance/20260122/35ed3bd382d74022a8944c418ab5a2f9/c.html
- East Money: https://caifuhao.eastmoney.com/news/20260122173041264150470
- Securities Star: https://finance.stockstar.com/IG2026012200029628.shtml
- China Economic Net: http://fashion.ce.cn/xx/202601/t20260122_2720931.shtml
- China.org.cn: http://zw.china.com.cn/2026-01/22/content_118294944.shtml
- Xinhua News Agency App: https://app.xinhuanet.com/news/article.html?articleId=09db4c011f9550b205db108ade18a0ab×tamp=41224
- Shaanxi Net: https://www.ishaanxi.com/c/2026/0122/3604678.shtml
- Phoenix News: https://ishare.ifeng.com/c/s/v002CC-_tCoEjc1vaEu--DkWUZRn1bRZ8v4ga4Lz5wPbXxWz8
- Strong Nation Channel: https://article.xuexi.cn/articles/index.html?art_id=14058336629264319339& item_id=14058336629264319339&study_style_id=feeds_opaque&pid=&ptype=-1&source=share&share_to=wx_single
- China Daily Website: https://qiye.chinadaily.com.cn/a/202601/23/WS6972ee3ca310942cc499c785.html
About Xinhuanet, Phoenix News, Chinadaily, Xinhua News Agency and China Economic Net
- Xinhuanet, the flagship online platform of China's state news agency Xinhua, provides authoritative, multilingual news coverage from over 150 countries, serving as the trusted digital gateway for global readers to understand China.
- Phoenix News is the comprehensive portal under Phoenix New Media, leveraging the strong resources of the Phoenix Television Group. It provides news and information services to Chinese audiences worldwide.
- chinadaily.com.cn is the official website of China Daily, China's national English-language newspaper. It is now one of the country's six key national media websites. As China's largest English-language information portal, it serves as the flagship platform for international communication under the State Council Information Office.
- Xinhua News Agency is the official state news agency of the People's Republic of China and one of the world's leading international news agencies. It operates as a ministry-level institution directly under the State Council. Together with People's Daily and China Media Group, Xinhua forms the highest echelon of China's official media landscape
- China Economic Net (CE.cn) is a key national news website sponsored by the Economic Daily, a comprehensive newspaper under the leadership of the State Council and the Publicity Department of the Central Committee of the CPC. It is one of China's eight key national news websites and currently the largest and most comprehensive economic portal in the country.